HUA LI

Director and supervisor of Research and Development of Clinical Laboratory Technology at Sterling Pathology National Laboratories, Dr. Hua Li received his Ph.D. from China Agricultural University in Beijing, China. After his postdoctoral fellowship at the School of Life Sciences at Tsinghua University in Beijing, Dr. Li moved to the United States and continued his postdoctoral work as a researcher within the Department of Medicine at Northwestern University in Chicago, IL. Dr. Li’s research has contributed to the development of Next Generation Sequencing (NGS) based LDT assays in the field of molecular oncology and genetics.